Kampala, Uganda | THE INDEPENDENT | Scientists attending the world’s first international conference on the triple elimination of HIV, syphilis, and hepatitis B have raised alarm over the continued neglect of syphilis prevention and control efforts, despite the infection’s growing burden across the African continent. Speaking at the ongoing conference …
Read More »
KAMPALA, UGANDA | Xinhua | Health experts, policymakers, and researchers on Monday began a three-day meeting in Kampala, the Ugandan capital, to accelerate the elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B across Africa. The event, held under the theme “Unifying Actions, Transforming Futures: Achieving Triple Elimination in …
Read More »
Kigali, Uganda | THE INDEPENDENT | In a major stride towards eliminating mother-to-child transmission of HIV, hepatitis B, and syphilis, Abbott, a global healthcare company, has unveiled a WHO-approved ANC panel designed to transform antenatal care across Africa. The Determine Antenatal Care Panel (ANC Panel) launched during the IAS2025 conference …
Read More »
Innovation, inclusion, and urgency define Kigali HIV conference ANALYSIS | RONALD MUSOKE | When the 13th International AIDS Society (IAS) Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13–17), delegates left with a mix of hope and concern—buoyed by scientific breakthroughs but unsettled by a deepening …
Read More »
But not fast enough to meet 2030 targets ANALYSIS | MELODY CHIRONDA | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that the global AIDS response is in crisis after a major funding collapse at the start of 2025 threatens to reverse decades of progress. New data reveals that …
Read More »
Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD MUSOKE | Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to …
Read More »
Kampala, Uganda | THE INDEPENDENT | HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for Pre-Exposure Prophylaxis (PrEP) under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a new modelling study warns. The pre-print study, led by Dr. Jack Stone, Associate Professor …
Read More »
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV. In 2012, the U.S. Food and Drugs Authority (FDA) had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are also approved. …
Read More »
Kampala, Uganda | THE INDEPENDENT | The Permanent Secretary of the Ministry of Health has expressed disappointment over poor health indicators within the population in the Greater Luwero districts despite a big budget allocation. According to the District Health report for 2023/24, at least 27% of outpatients were suffering from malaria, …
Read More »
GENEVA, Switzerland | THE INDEPENDENT | The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by injection once every 6 months and is a significant step in improving prevention options for people at risk of HIV infection around the …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
